Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Armistice Capital

Investor type Hedge Fund

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 8
Average round size
info
The average size of a deal this fund participated in
$18M
Portfolio companies 8
Lead investments 0
Exits 8
Key employees 1

Areas of investment

  • Biotechnology
  • Pharmaceutical
  • Medical
  • Health Care
  • Medical Device
Summary

Besides, a startup needs to be aged 11-15 years to get the investment from the fund. Among the most popular fund investment industries, there are Medical, Manufacturing. Among the most popular portfolio startups of the fund, we may highlight Addex Therapeutics, Medigus.

The overall number of key employees were 1.

The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Armistice Capital, startups are often financed by Varuma AG, Sofinnova Partners, SR One. The meaningful sponsors for the fund in investment in the same round are Senvest Capital, Sabby Management, OrbiMed. In the next rounds fund is usually obtained by Hercules Bioventure Partners, Michael J. Fox Foundation.

Deals in the range of 5 - 10 millions dollars are the general things for fund. The fund is constantly included in less than 2 deals per year. The higher amount of exits for fund were in 2018. The high activity for fund was in 2013.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Armistice Capital:
Typical Co-investors
Armistice Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Armistice Capital:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Astmax Japan, Tokyo
D.Phone Beijing, Beijing, China
ICT Group N.V. Barendrecht, The Netherlands, Zuid-Holland
Innovative Medicines Initiative Belgium, Berchem, Brussels-Capital
InnoWerft Baden-Wurttemberg, Germany, Walldorf
Kunda Technology -
Liberty Israel Venture Fund Israel, Tel Aviv, Tel Aviv District
Likang Zhihui Yiliao Baoshan, China, Shanghai
LiquidPrice.com California, Cupertino, United States
Londonderry Management New York, New York, United States
Molex Ventures Illinois, Lisle, United States
New Avenue Capital -
Noble Partners -
Shikong Wuxing China, Shanghai
Taya Investment Company Ltd -
Teikoku Databank Japan, Tokyo
The Kiyo Lease & Capital Japan, Wakayama, Wakayama Prefecture
Times Internet Gurgaon, Haryana, India
TowerComm North Carolina, Raleigh, United States
Whitefish Ventures Minnesota, Minnesota City, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Provention Bio

Biotechnology
Health Care
Medical
Pharmaceutical
$60M07 Jul 2022 New Jersey, United States

Eyenovia

Biotechnology
Pharmaceutical
$15M04 Mar 2022 New York, New York, United States

Xeris Pharmaceuticals

Biotechnology
Diabetes
Health Care
Pharmaceutical
Therapeutics
$30M03 Jan 2022 Chicago, Illinois, United States

erytech

Biopharma
Biotechnology
Medical
$7M13 Dec 2021 Lyon, Auvergne-Rhône-Alpes, France

Mauna Kea Technologies

Biotechnology
Medical
Medical Device
$14M24 Sep 2021 Paris, Ile-de-France, France

EyeGate Pharmaceuticals

Biotechnology
Medical
Pharmaceutical
$8M06 Jan 2021 Massachusetts, United States

Medigus

Biotechnology
Health Care
Manufacturing
Medical Device
$11M29 Jun 2014 North District

Addex Therapeutics

Biotechnology
Health Care
Medical
Pharmaceutical
$3M09 Aug 2013 Geneva, Switzerland

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Armistice Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: